/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR
DISSEMINATION IN THE UNITED
STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY
CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW./
TORONTO, May 25, 2015 /CNW/ - Mira IV Acquisition
Corp. ("Mira IV"; TSX Venture: MRY.P) is pleased to announce
that it has received conditional acceptance from the TSX Venture
Exchange (the "TSXV") in respect of its qualifying
transaction (the "Transaction") with Profound Medical Inc.
("Profound") pursuant to Policy 2.4 - Capital Pool
Companies of the TSXV.
In accordance with the previously announced amalgamation
agreement dated April 29, 2015, Mira
IV Subco Inc., a wholly-owned subsidiary of Mira IV, will
amalgamate with Profound. The Transaction is expected to close on
or about June 4, 2015.
Filing Statement
In connection with the Transaction and pursuant to TSXV
requirements, Mira IV has filed a filing statement dated
May 22, 2015 on SEDAR
(www.sedar.com).
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any securities in any
jurisdiction.
ANY SECURITIES REFERRED TO HEREIN WILL NOT BE REGISTERED UNDER
THE U.S. SECURITIES ACT OF 1933 (THE "1933 ACT") AND MAY NOT BE
OFFERED OR SOLD IN THE UNITED
STATES OR TO A U.S. PERSON IN THE ABSENCE OF SUCH
REGISTRATION OR AN EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF
THE 1933 ACT.
Notice regarding forward-looking statements:
This release includes forward-looking statements regarding
Mira IV, Profound and their respective businesses, which may
include, but is not limited to, statements with respect to the
completion of the Transaction, the ability to obtain regulatory
approvals and other factors. Often, but not always, forward-looking
statements can be identified by the use of words such as "plans",
"is expected", "expects", "scheduled", "intends", "contemplates",
"anticipates", "believes", "proposes" or variations (including
negative variations) of such words and phrases, or state that
certain actions, events or results "may", "could", "would", "might"
or "will" be taken, occur or be achieved. Such statements are based
on the current expectations of the management of each entity. The
forward-looking events and circumstances discussed in this release,
including completion of the Transaction, may not occur by certain
specified dates or at all and could differ materially as a result
of known and unknown risk factors and uncertainties affecting the
companies, including risks regarding the pharmaceutical industry,
failure to obtain regulatory or shareholder approvals, economic
factors, the equity markets generally and risks associated with
growth and competition. Although Mira IV and Profound have
attempted to identify important factors that could cause actual
actions, events or results to differ materially from those
described in forward-looking statements, there may be other factors
that cause actions, events or results to differ from those
anticipated, estimated or intended. No forward-looking statement
can be guaranteed. Except as required by applicable securities
laws, forward-looking statements speak only as of the date on which
they are made and Mira IV and Profound undertake no obligation to
publicly update or revise any forward-looking statement, whether as
a result of new information, future events, or otherwise.
SOURCE Mira IV Acquisition Corp.